Dr. Zamar Raza, M.D

NPI: 1548445687
Total Payments
$13.90
2021 Payments
$13.90
Companies
1
Transactions
1
Medicare Patients
3,391
Medicare Billing
$249,326

Payment Breakdown by Category

Food & Beverage$13.90 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13.90 1 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $13.90 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2021 $13.90 1 AstraZeneca Pharmaceuticals LP ($13.90)

All Payment Transactions

1 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/17/2021 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $13.90 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 871 1,048 $231,230 $59,321
2022 10 978 1,102 $227,955 $76,701
2021 8 907 950 $219,420 $68,344
2020 11 635 705 $180,845 $44,960
Total Patients
3,391
Total Services
3,805
Medicare Billing
$249,326
Procedure Codes
40

All Medicare Procedures & Services

40 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 374 465 $134,040 $36,385 27.1%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2023 164 186 $30,690 $7,531 24.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 92 92 $36,680 $7,484 20.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 17 18 $7,190 $1,889 26.3%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 53 112 $6,680 $1,817 27.2%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 42 43 $6,450 $1,489 23.1%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2023 17 17 $2,700 $854.76 31.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 11 11 $1,850 $688.24 37.2%
87428 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza Office 2023 19 19 $2,980 $576.08 19.3%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2023 29 30 $1,500 $486.00 32.4%
81003 Automated urinalysis test Office 2023 53 55 $470.00 $121.00 25.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 410 459 $119,745 $43,415 36.3%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2022 151 158 $24,700 $8,016 32.5%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 183 204 $30,600 $7,096 23.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 48 48 $18,240 $6,773 37.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 35 35 $13,475 $4,218 31.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 43 44 $7,040 $2,881 40.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 13 13 $7,275 $2,416 33.2%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 46 92 $4,600 $1,467 31.9%
87428 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza Office 2022 11 11 $2,090 $335.38 16.0%
81003 Automated urinalysis test Office 2022 38 38 $190.00 $84.10 44.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 351 367 $95,475 $34,660 36.3%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 91 91 $34,965 $10,302 29.5%
87426 Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 200 217 $32,550 $7,667 23.6%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 121 124 $31,000 $6,362 20.5%

About Dr. Zamar Raza, M.D

Dr. Zamar Raza, M.D is a Primary Care healthcare provider based in Bedford, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1548445687.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zamar Raza, M.D has received a total of $13.90 in payments from pharmaceutical and medical device companies, with $13.90 received in 2021. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($13.90).

As a Medicare-enrolled provider, Raza has provided services to 3,391 Medicare beneficiaries, totaling 3,805 services with total Medicare billing of $249,326. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.

Practice Information

  • Specialty Primary Care
  • Other Specialties Family Medicine
  • Location Bedford, MA
  • Active Since 01/08/2008
  • Last Updated 06/07/2025
  • Taxonomy Code 261QP2300X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1548445687

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Primary Care Doctors in Bedford